Big difference in stage mate, DXB late stage ph3 which has already interim readout.
ACW still very high risk for any type of licence deal.
- Forums
- ASX - By Stock
- ACW
- Ann: Actinogen March 2025 quarterly activity report & Appendix 4C
ACW
actinogen medical limited
Add to My Watchlist
0.00%
!
2.5¢

Ann: Actinogen March 2025 quarterly activity report & Appendix 4C, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $79.42M |
Open | High | Low | Value | Volume |
2.4¢ | 2.5¢ | 2.4¢ | $2.331K | 93.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 954666 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 951681 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 954666 | 0.024 |
7 | 3000508 | 0.023 |
14 | 1973323 | 0.022 |
11 | 2304093 | 0.021 |
11 | 2325000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 911681 | 5 |
0.026 | 777384 | 5 |
0.027 | 561238 | 5 |
0.028 | 622900 | 5 |
0.029 | 1233142 | 3 |
Last trade - 11.41am 12/08/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |